OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Third COVID-19 vaccine dose boosts neutralizing antibodies in poor responders
Douglas F. Lake, Alexa J. Roeder, María J. González‐Moa, et al.
Communications Medicine (2022) Vol. 2, Iss. 1
Open Access | Times Cited: 12
Douglas F. Lake, Alexa J. Roeder, María J. González‐Moa, et al.
Communications Medicine (2022) Vol. 2, Iss. 1
Open Access | Times Cited: 12
Showing 12 citing articles:
Tracking Immunity: An Increased Number of COVID-19 Boosters Increases the Longevity of Anti-RBD and Anti-RBD-Neutralizing Antibodies
Ching‐Wen Hou, Stacy Williams, Veronica Boyle, et al.
Vaccines (2025) Vol. 13, Iss. 1, pp. 61-61
Open Access
Ching‐Wen Hou, Stacy Williams, Veronica Boyle, et al.
Vaccines (2025) Vol. 13, Iss. 1, pp. 61-61
Open Access
Gold nanoparticle–based lateral-flow immunochromatographic biosensing assays for the diagnosis of infections
О. I. Guliy, Л. А. Дыкман
Biosensors and Bioelectronics X (2024) Vol. 17, pp. 100457-100457
Open Access | Times Cited: 4
О. I. Guliy, Л. А. Дыкман
Biosensors and Bioelectronics X (2024) Vol. 17, pp. 100457-100457
Open Access | Times Cited: 4
Extending the dosing interval of COVID-19 vaccination leads to higher rates of seroconversion in people living with HIV
Yi Wang, Jianhua Li, Wenhui Zhang, et al.
Frontiers in Immunology (2023) Vol. 14
Open Access | Times Cited: 8
Yi Wang, Jianhua Li, Wenhui Zhang, et al.
Frontiers in Immunology (2023) Vol. 14
Open Access | Times Cited: 8
Prolonged SARS-CoV-2 T Cell Responses in a Vaccinated COVID-19-Naive Population
Vassiliki Pitiriga, Myrto Papamentzelopoulou, Kanella E. Konstantinakou, et al.
Vaccines (2024) Vol. 12, Iss. 3, pp. 270-270
Open Access | Times Cited: 2
Vassiliki Pitiriga, Myrto Papamentzelopoulou, Kanella E. Konstantinakou, et al.
Vaccines (2024) Vol. 12, Iss. 3, pp. 270-270
Open Access | Times Cited: 2
Overlaid Lateral Flow Immunoassay for the Simultaneous Detection of Two Variant-Specific SARS-CoV-2 Neutralizing Antibodies
Wanwisa Deenin, Nanthika Khongchareonporn, Kiat Ruxrungtham, et al.
Analytical Chemistry (2024) Vol. 96, Iss. 14, pp. 5407-5415
Open Access | Times Cited: 1
Wanwisa Deenin, Nanthika Khongchareonporn, Kiat Ruxrungtham, et al.
Analytical Chemistry (2024) Vol. 96, Iss. 14, pp. 5407-5415
Open Access | Times Cited: 1
Heterogeneity of SARS-CoV-2 immune responses after the nationwide Omicron wave in China
Jing Wu, Mingzheng Jiang, Jiwei Li, et al.
Microbiology Spectrum (2024)
Open Access | Times Cited: 1
Jing Wu, Mingzheng Jiang, Jiwei Li, et al.
Microbiology Spectrum (2024)
Open Access | Times Cited: 1
Intranasal Immunization with a Vaccinia Virus Vaccine Vector Expressing Pre-Fusion Stabilized SARS-CoV-2 Spike Fully Protected Mice against Lethal Challenge with the Heavily Mutated Mouse-Adapted SARS2-N501YMA30 Strain of SARS-CoV-2
Karen V. Kibler, Mateusz Szczerba, Douglas F. Lake, et al.
Vaccines (2022) Vol. 10, Iss. 8, pp. 1172-1172
Open Access | Times Cited: 9
Karen V. Kibler, Mateusz Szczerba, Douglas F. Lake, et al.
Vaccines (2022) Vol. 10, Iss. 8, pp. 1172-1172
Open Access | Times Cited: 9
Longitudinal Comparison of Neutralizing Antibody Responses to COVID-19 mRNA Vaccines after Second and Third Doses
Alexa J. Roeder, Megan Koehler, Paniz Jasbi, et al.
Vaccines (2022) Vol. 10, Iss. 9, pp. 1459-1459
Open Access | Times Cited: 6
Alexa J. Roeder, Megan Koehler, Paniz Jasbi, et al.
Vaccines (2022) Vol. 10, Iss. 9, pp. 1459-1459
Open Access | Times Cited: 6
Intranasal immunization with a vaccinia virus vaccine vector expressing pre-fusion stabilized SARS-CoV-2 spike fully protected mice against lethal challenge with the heavily mutated mouse-adapted SARS2-N501YMA30 strain of SARS-CoV-2
Karen V. Kibler, Mateusz Szczerba, Douglas F. Lake, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2021)
Open Access | Times Cited: 8
Karen V. Kibler, Mateusz Szczerba, Douglas F. Lake, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2021)
Open Access | Times Cited: 8
Detecting SARS-CoV-2 neutralizing immunity: highlighting the potential of split nanoluciferase technology
Sundararaj Stanleyraj Jeremiah, Kei Miyakawa, Akihide Ryo
Journal of Molecular Cell Biology (2022) Vol. 14, Iss. 4
Open Access | Times Cited: 5
Sundararaj Stanleyraj Jeremiah, Kei Miyakawa, Akihide Ryo
Journal of Molecular Cell Biology (2022) Vol. 14, Iss. 4
Open Access | Times Cited: 5
Neutralizing Antibody Response following a Third Dose of the mRNA-1273 Vaccine among Cancer Patients
Christopher W. Dukes, Marine Potez, Jeffrey E. Lancet, et al.
Vaccines (2023) Vol. 12, Iss. 1, pp. 13-13
Open Access | Times Cited: 1
Christopher W. Dukes, Marine Potez, Jeffrey E. Lancet, et al.
Vaccines (2023) Vol. 12, Iss. 1, pp. 13-13
Open Access | Times Cited: 1
The relationship between the number of COVID-19 vaccines and infection with Omicron ACE2 inhibition at 18-months post initial vaccination in an adult cohort of Canadian paramedics
Justin Yap, Iryna Kayda, Michael Asamoah-Boaheng, et al.
Access Microbiology (2023) Vol. 5, Iss. 11
Open Access
Justin Yap, Iryna Kayda, Michael Asamoah-Boaheng, et al.
Access Microbiology (2023) Vol. 5, Iss. 11
Open Access
